Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026 and Sep 2026.
- Largest single sale: $6.2M (22,527 shares) of Johnson & Johnson on Sep 2, 2026. Filing
- Last sale before this period: Feb 18, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Johnson & Johnson (JNJ) | EVP, WW Chair, MedTech | Nov 2, 2023 | Sep 4, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 2, 2026, Johnson & Johnson: sold 33,597 shares for $9.2M, no plan disclosed; 33,597 shares acquired by exercising options. 1 filing: 1
- Feb 20, 2026, Johnson & Johnson: sold 1,322 shares for $325K, no plan disclosed. 1 filing: 1
- Feb 18, 2026, Johnson & Johnson: sold 22,623 shares for $5.5M, no plan disclosed; 22,623 shares acquired by exercising options. 1 filing: 1
- Feb 15, 2026, Johnson & Johnson: 2,054 shares vested; 463 shares withheld by the company for taxes. 1 filing: 1
- Feb 13, 2026, Johnson & Johnson: 4,877 shares vested; 1,824 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.